Experimental cerebral infarction: modification by treatment with hemodiluting, hemoconcentrating, and dehydrating agents.
D000818:Animals; D001929:Brain Edema / Q000188:drug therapy; D002415:Cats; D002539:Cerebral Arterial Diseases / Q000188:drug therapy*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003681:Dehydration; D003911:Dextrans / Q000627:therapeutic use*; D004912:Erythrocytes; D007238:Infarction / Q000188:drug therapy*; D006435:Renal Dialysis; D012709:Serum Albumin / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000627:therapeutic use; D014508:Urea / Q000627:therapeutic use*
D003911:Dextrans; D012709:Serum Albumin; D012965:Sodium Chloride; D014508:Urea